Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentian violet plus oral fluconazole for vaginal candidiasis
TCTR20170324004Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in vulvovaginal candidiasis (VVC) comparing Fluconazole control with Fluconazole plus gentian violet (2 arms). Primary endpoint: Treatment success rate. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
fluconazolegentian violet
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on TCTR20170324004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170324004.